Long-Term Efficacy and Safety of Sodium Channel Antagonists in Patients With p.R222Q SCN5A-Related Arrhythmic Dilated Cardiomyopathy

Grants

Funding Acknowledgements

Dr. Peters is supported by a Commonwealth Research Training Program scholarship from the University of Melbourne and a Melbourne Health Research Fellowship grant. Dr. Kalman is funded by a Practitioner Fellowship of the National Health and Medical Research Council of Australia (NHMRC). Dr. Fatkin receives support from the Victor Chang Cardiac Research Institute, NHMRC, NSW Health, and the Estate of the Late R.T. Hall. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose Andrew Krahn, MD, served as Guest Editor for this paper. William Stevenson, MD, served as Guest Editor-in-Chief for this paper.